Evidence map›Paper›PMID 35288348›Full record

ArticleVirologica Sinica2022

Construction and verification of an infectious cDNA clone of coxsackievirus B5.

Lifang Song, Bopei Cui, Jinghuan Yang, Xiaotian Hao, Xujia Yan, Jialu Zhang, Dong Liu, Ziyang Song, Qian Wang, Qunying Mao and 1 more

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Virologica Sinica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lifang SongNational Institute for Food and Drug Control, Beijing 102629, China.
Bopei CuiNational Institute for Food and Drug Control, Beijing 102629, China; Wuhan Institute of Biological Products CO., LTD, Wuhan 430070, China.
Jinghuan YangNational Institute for Food and Drug Control, Beijing 102629, China.
Xiaotian HaoNational Institute for Food and Drug Control, Beijing 102629, China.
Xujia YanNational Institute for Food and Drug Control, Beijing 102629, China.
Jialu ZhangNational Institute for Food and Drug Control, Beijing 102629, China.
Dong LiuNational Institute for Food and Drug Control, Beijing 102629, China.
Ziyang SongNational Institute for Food and Drug Control, Beijing 102629, China.
Qian WangNational Institute for Food and Drug Control, Beijing 102629, China.
Qunying MaoNational Institute for Food and Drug Control, Beijing 102629, China. Electronic address: maoqunying@126.com.
Zhenglun LiangNational Institute for Food and Drug Control, Beijing 102629, China. Electronic address: lzhenglun@126.com.
National Institutes for Food and Drug Control · CNWuhan Institute of Bioengineering · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coxsackievirus InfectionsEnterovirus B, HumanClone CellsCloning, MolecularDNA, ComplementaryHumansDNA, Complementary

Identifiers

PMID35288348
PMCPMC9707635
OpenAlexW4220726236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.